Mounting Success in Trials of Genetically Engineered T Cells to Treat Leukemias and Lymphomas

Mounting Success in Trials of Genetically Engineered T Cells to Treat Leukemias and Lymphomas

‘>Tweet this page

David L. Porter, MD

Stephan A. Grupp, MD, PhD

Michael Kalos, PhD

James N. Kochenderfer, MD

Reports have been trickling in from centers conducting research on the use of chimeric antigen receptor–modified T cells (CAR-T) in hematologic cancer, and the news is encouraging. Continue reading →